Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
James C. Yao, Emily K. Bergsland, Rahul Aggarwal, et al.
The Oncologist (2022) Vol. 27, Iss. 11, pp. 940-951
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
Charles M. Rudin, Martin Reck, Melissa L. Johnson, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 80
Bispecific and multispecific antibodies in oncology: opportunities and challenges
Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 539-560
Closed Access | Times Cited: 37
Advances and challenges in precision imaging
Hedvig Hricak, Marius E. Mayerhoefer, Ken Herrmann, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 1, pp. e34-e45
Closed Access | Times Cited: 5
Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
Kristina Krpina, Semir Vranić, Krešimir Tomić, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1982-1982
Open Access | Times Cited: 23
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Salomon Tendler, Mark Dunphy, Matthew Agee, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. 1015-1024
Closed Access | Times Cited: 13
Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms
Arielle Urman, Ian Schonman, Ana De Jesus‐Acosta
Current Treatment Options in Oncology (2025)
Closed Access | Times Cited: 1
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
John Maher, David M. Davies
Cancers (2023) Vol. 15, Iss. 4, pp. 1171-1171
Open Access | Times Cited: 18
Updates on lung neuroendocrine neoplasm classification
Giulia Trucco, Luisella Righi, Marco Volante, et al.
Histopathology (2023) Vol. 84, Iss. 1, pp. 67-85
Open Access | Times Cited: 17
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
Hirofumi Mikami, Shu Feng, Yutaka Matsuda, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 6, pp. 719-730
Closed Access | Times Cited: 7
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
Azra Ajkunic, Erolcan Sayar, Martine P. Roudier, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 7
TREM1/DAP12 based novel multiple chain CAR‐T cells targeting DLL3 show robust anti‐tumour efficacy for small cell lung cancer
Fengqi Nie, Yu‐Li Chen, Yanming Hu, et al.
Immunology (2024) Vol. 172, Iss. 3, pp. 362-374
Closed Access | Times Cited: 6
Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy
Shenghao Wang, Sikuan Gu, Junfan Chen, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 480-480
Open Access | Times Cited: 5
Magnetic Resonance Imaging of the Gastrointestinal Tract: Current Role, Recent Advancements and Future Prospectives
Francesca Maccioni, Ludovica Busato, Alessandra Valenti, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2410-2410
Open Access | Times Cited: 12
Updates on Urinary Bladder Tumors With Neuroendocrine Features
Dilara Akbulut, Hikmat Al‐Ahmadie
Advances in Anatomic Pathology (2024) Vol. 31, Iss. 3, pp. 169-177
Closed Access | Times Cited: 4
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min Yuen Teo, et al.
Modern Pathology (2024) Vol. 37, Iss. 10, pp. 100557-100557
Closed Access | Times Cited: 4
Adopting tomorrow’s therapies today: a perspective review of adoptive cell therapy in lung cancer
Faith Abodunrin, Daniel J. Olson, Oluwatosin Emehinola, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Novel erbium complex with anticancer activity against radiation resistant lung adenocarcinoma cells
Hao Wang, Guosheng Ren, Yue Xu, et al.
Journal of Inorganic Biochemistry (2025), pp. 112902-112902
Closed Access
Facile Synthesis of CuFe2O4 Magnetic Nanospheres with High Separation Efficiency for Histidine‐Rich Proteins
Tong Tong, Qingjiang Yu, Siqi Liu, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms
Maxime Schmitt, Hanibal Bohnenberger, Detlef K. Bartsch, et al.
Endocrine Pathology (2025) Vol. 36, Iss. 1
Open Access
Tumores Neuroendocrinos Gastroenteropancreáticos
Andrés Rodríguez, Greta Catani, Oscar Andriani, et al.
Oncología Clínica (2025) Vol. 30, Iss. 1
Closed Access
Targeting DLL3: Innovative Strategies for Tumor Treatment
Hui Wang, Tong Zheng, Dan Xu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 520-520
Open Access
Immuntherapie bei neuroendokrinen Neoplasien des Gastrointestinaltrakts
Sebastian Krug, Leonidas Apostolidis
Deleted Journal (2025)
Closed Access
Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis
Hong Li, Chi‐Ling Chiang, Kwang Joo Kwak, et al.
Advanced Science (2025)
Open Access
Lung NETs and GEPNETs: One Cancer with Different Origins or Two Distinct Cancers?
George Evangelou, Ioannis Vamvakaris, Anastasia Papafili, et al.
(2024)
Open Access | Times Cited: 3
Small Cell Lung Cancer Neuronal Features and Their Implications for Tumor Progression, Metastasis, and Therapy
Griffin G. Hartmann, Julien Sage
Molecular Cancer Research (2024) Vol. 22, Iss. 9, pp. 787-795
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top